Dronedarone in High-Risk Permanent Atrial Fibrillation

Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial)

(2011) Richard L. Page et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart Failure

(2010) T. Barry Levine et al.   CARDIOVASCULAR DRUGS AND THERAPY

A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians

(2010) J. Chikwe et al.   EUROPEAN HEART JOURNAL

Dronedarone in patients with congestive heart failure: insights from ATHENA

(2010) S. H. Hohnloser et al.   EUROPEAN HEART JOURNAL

Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter

(2009) Stuart J. Connolly et al.   CIRCULATION

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

(2009) Stefan H. Hohnloser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

(2008) R. Nieuwlaat et al.   EUROPEAN HEART JOURNAL

Increased Mortality after Dronedarone Therapy for Severe Heart Failure

(2008) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE